While the research on prostate cancer is extensive, this research does not estimate an overall cost, considering all the direct (e.g., appointments and medication) and indirect (e.g., dealing with complications) costs associated with treatments of prostate cancer considering different risk levels ...
Comparing the costs of radiation therapy and radical prostatectomy for the initial treatment of early-stage prostate cancer. Radical prostatectomy and external-beam radiation are the most common treatments for localized prostate cancer. Given the absence of clinical consensus in ......
aFor example, there are a variety of treatments for prostate cancer, with wide variations in costs but no clear evidence of superiority for one type of treatment over another (Leonhardt, 2009). 例如,有各种各样的治疗为摄护腺癌,以变化繁多在费用,但没有优势的清楚的证据为一种治疗方式在另一 (...
(HealthDay)—Most patients with localized prostate cancer know little about the out-of-pocket expenses (OOPE) of the different treatments, and would not have chosen a different treatment even if they had known the actual OOPE of their treatment, according to a study published in the December ...
Limited data are available concerning long-term prostate cancer (PCa)-related medical costs for use in assessing PCa prevention strategies. The aim of this study was to examine treatment, long-term survival, and long-term PCa-related costs by cancer stage. Costs in phases of care based on the...
Sixty-four percent of T2 resources were used in primary sector and 11% at inpatient admissions, which was the highest percentage among the treatment regimes. T4 patients generally used more resources in the hospital sector compared to the other surgical treatments (T2 and T3). Table 2 Total ...
Rising costs of cancer treatments, compounded with increasing cost-sharing, increased out-of-pocket costs for privately insured, nonelderly patients with female breast, colorectal, lung, and prostate cancers, according to a recent study. Policy initiatives to mitigate financial hards...
Primary care physicians can be essential to managing comorbid conditions, chronic pain, and psychosocial needs of patients with cancer. Additionally, non-oncology specialists can help address the late effects of cancer and its treatments, such as infertility, cognitive dysfunction, and...
Adverse event (AE)-related costs represent an important component of economic models for cancer care. However, since previous studies mostly focused on specific AEs, treatments, or cancer types, limited information is currently available. Therefore, this study assessed the incremental healthcare costs ...
This potential drug was also found to enhance the therapeutic effects of enzalutamide, another small molecule currently used in the clinical treatment of prostate cancer. In the same year was the discovery of novel drug-like small molecules capable of reversing biological dysfunctions associated with ...